Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. to extend its PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The expanded relationship, announced July 30, 2026, is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. It leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models. The full press release is available at https://ibn.fm/vBAxH.
This expansion is significant as it moves blockchain-based health data management from a niche pharmaceutical logistics application into broader commercial healthcare, potentially giving patients more control over their medical data and creating new revenue streams through data monetization and tokenization. The move aligns with growing trends in patient data empowerment and the integration of AI and IoT in healthcare. Datavault AI's technology, including its Information Data Exchange and high-performance computing solutions, could enable secure data transactions and digital twins in healthcare settings.
Datavault AI (DVLT) is a leader in AI-driven data experiences, valuation, and monetization in the Web 3.0 environment. Its cloud-based platform serves multiple industries, including healthcare, through its Acoustic Sciences and Data Sciences divisions. The company's technology suite offers AI- and ML-based automation, third-party integration, and analytics. More information is available at https://dvlt.ai. The company's newsroom is at https://ibn.fm/DVLT.
